Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Proprietary Chinese medicine for treating apoplexy and sequela

A technology for traditional Chinese medicine and sequelae, which is applied in the directions of drug combinations, pharmaceutical formulas, and medical preparations containing active ingredients, etc. It can solve the problems of unoptimistic treatment of sequelae, unsatisfactory curative effect, and high cost of western medicine treatment, and achieve the goal of promoting traditional Chinese medicine. Low business and medical expenses, and the effect of reducing mental distress

Inactive Publication Date: 2008-06-11
郑林生
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the morbidity rate, disability rate, recurrence rate and mortality rate of cerebral apoplexy are relatively high. The curative effect of western medicine treatment is not bad in the acute stage, but the key point is that the recovery period and the treatment of sequelae are not optimistic, such as imported cerebrolysin, cranial nerve growth Vitamins, Naofukang, vitamin B complex, etc., the curative effect is not satisfactory
However, regular infusions have certain pain and irritation, such as small molecule reactions, and long-term intramuscular injection is not easy to absorb; oral administration of western medicine nausea, patients do not want to eat
In addition, the cost of western medicine treatment is high, which is unaffordable for ordinary patients, and the treatment is terminated as soon as the condition stabilizes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Embodiment 1: A kind of Chinese patent medicine for the treatment of apoplexy and its sequelae, containing the following dry raw materials, in parts by weight, 40 grams of Radix Astragali, 10 grams of Rhizoma Chuanxiong, 8 grams of Gastrodia elata, 7 grams of peach kernels, 12 grams of Danshen, and 6 grams of Dannanxing gram, 20 grams of yam, 8 grams of safflower, 10 grams of Achyranthes bidentata, 7 grams of ginger silkworm, and 10 grams of earthworm.

Embodiment 2

[0048] Embodiment two: basically the same as embodiment one, the difference is:

[0049] Raw materials: Astragalus 30 grams, Chuanxiong 5 grams, Gastrodia elata 3 grams, peach kernel 5 grams, Danshen 5 grams, Dannanxing 3 grams, yam 10 grams, safflower 5 grams, Achyranthes bidentata 5 grams, ginger silkworm 5 grams, earthworm 5 grams gram.

Embodiment 3

[0050] Embodiment three: basically the same as embodiment one, the difference is:

[0051] Raw materials: 60 grams of Astragalus, 15 grams of Chuanxiong, 15 grams of Tianma, 9 grams of peach kernels, 20 grams of Danshen, 9 grams of Dannanxing, 30 grams of yam, 9 grams of safflower, 15 grams of Achyranthes bidentata, 12 grams of ginger silkworm, and 15 grams of earthworm gram.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a Chinese traditional patent medicine, in particular to a Chinese traditional patent medicine for curing apoplexy and apoplectic sequela. The Chinese traditional patent medicine comprises following dry raw materials with part by weight as unit: astragalus 30-60 parts, ligusticum chuanxiong 5-15 parts, rhizome gasdtrodiae 3-15 parts, peach kernel 5-9 parts, salvia miltiorrhizae 5-20 parts, arisaema cum bile 3-9 parts, Chinese yam 10-30 parts, safflower 5-12 parts, achyranthes root 5-15 parts, ginger silkworm 5-12 parts and lumbricus 5-12 parts. Confirmed by clinical experiments, the invention has reasonable formulation, proper compatibility, precise and special medication, curative rate is up to 83.0%, and effective rate is up to 99.3%. The medicament can cure diseases both on symptoms and root cause, and curative effect is solid, the disease can not easily recrudesce after healing, curative method is simple without stimulation and toxic and side effects, and the invention is easily accepted by patients.

Description

1. Technical field: [0001] The invention relates to a Chinese patent medicine, in particular to a Chinese patent medicine for treating apoplexy and sequelae. 2. Background technology: [0002] Ischemic stroke is a common disease in neurology. It is often caused by social and psychological factors such as hypertension, hyperlipidemia, diabetes, obesity, genetics, diet, etc., resulting in neuronal damage or necrosis, localized or diffuse brain function deficits. [0003] In recent years, with the increasing aging of the population, the research on the prevention and treatment of stroke and encephalopathy has been paid more and more attention by the medical community. Modern high-tech technology and the combination of traditional Chinese and Western medicine have effectively promoted the scientific development of apoplexy and encephalopathy. Cerebral stroke is a common disease that seriously endangers human health, and is one of the main factors causing death and disability i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8988A61K9/14A61K9/20A61K9/48A61P9/10A61P25/00A61K35/64A61K35/62
Inventor 郑林生郑光辉郑光亮
Owner 郑林生
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products